FATE Fate Therapeutics, Inc.
$1.94
Fate Therapeutics, Inc. (FATE) SEC Filings
Everything FATE has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.
| Date | Form | Filing |
|---|---|---|
| SCHEDULE 13D/A | View filing | |
| 8-K Agreement Terminated · Capital Raise · Material Agreement | View filing | |
| 10-Q | View filing | |
| 8-K Earnings Release · Executive Change · Guidance Update · Other | View filing | |
| 4 | View filing | |
| 144 | View filing | |
| 8-K Other Event · Other Reg Fd | View filing | |
| 10-Q | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 10-Q | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4/A | View filing | |
| 4 | View filing | |
| 10-K | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 10-Q | View filing | |
| 4 | View filing | |
| 10-Q | View filing | |
| 10-Q | View filing | |
| 10-K | View filing | |
| 10-Q | View filing | |
| 10-Q | View filing | |
| 10-Q | View filing | |
| 10-K | View filing | |
| 10-Q | View filing | |
| 10-Q | View filing | |
| 10-Q | View filing | |
| 10-K | View filing | |
| 10-Q | View filing | |
| 10-Q | View filing | |
| 10-Q | View filing | |
| 10-K | View filing | |
| 10-Q | View filing |
Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.